| Dr Hesham M Elghannam, MD | |
|
2424 S 90th St Ste 300, West Allis, WI 53227-2455 | |
| (414) 328-8150 | |
| Not Available |
| Full Name | Dr Hesham M Elghannam |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 28 Years |
| Location | 2424 S 90th St Ste 300, West Allis, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023212289 | NPI | - | NPPES |
| 100033017 | Medicaid | WI | |
| 0235677 | Other | WA | WA STATE LABOR & INDUSTRIES |
| 8509416 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 61317 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Allis Memorial Hospital | West allis, WI | Hospital |
| Aurora Medical Center - Summit | Summit, WI | Hospital |
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
In a study that included 3.3 million percutaneous coronary intervention procedures, major bleeding after PCI was associated with significantly increased in-hospital mortality, with an estimated 12 percent of deaths after PCI related to bleeding complications, according to a study appearing in the March 13 issue of JAMA.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight® Dx Pulmotax™ assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC," included 368 samples from carcinoma patients.
The cancer medication bexarotene, aka Targretin, made headlines when researchers reported that it quickly lowered Aβ in the brain, reduced amyloid plaques, and improved learning and memory in mice that mimic salient features of Alzheimer's disease (AD).
For neuroscientists studying the intricate mechanisms of hearing in the brain's auditory cortex, a major question has been how a listener can focus in a noisy environment, and how neurochemicals help neurons convey as much embedded information as possible for the rest of the brain to act on.
› Verified 4 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
In a study that included 3.3 million percutaneous coronary intervention procedures, major bleeding after PCI was associated with significantly increased in-hospital mortality, with an estimated 12 percent of deaths after PCI related to bleeding complications, according to a study appearing in the March 13 issue of JAMA.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight® Dx Pulmotax™ assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC," included 368 samples from carcinoma patients.
The cancer medication bexarotene, aka Targretin, made headlines when researchers reported that it quickly lowered Aβ in the brain, reduced amyloid plaques, and improved learning and memory in mice that mimic salient features of Alzheimer's disease (AD).
For neuroscientists studying the intricate mechanisms of hearing in the brain's auditory cortex, a major question has been how a listener can focus in a noisy environment, and how neurochemicals help neurons convey as much embedded information as possible for the rest of the brain to act on.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hesham M Elghannam, MD 2424 S 90th St Ste 300, West Allis, WI 53227-2455 Ph: (414) 328-8150 | Dr Hesham M Elghannam, MD 2424 S 90th St Ste 300, West Allis, WI 53227-2455 Ph: (414) 328-8150 |
News Archive
In a study that included 3.3 million percutaneous coronary intervention procedures, major bleeding after PCI was associated with significantly increased in-hospital mortality, with an estimated 12 percent of deaths after PCI related to bleeding complications, according to a study appearing in the March 13 issue of JAMA.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight® Dx Pulmotax™ assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC," included 368 samples from carcinoma patients.
The cancer medication bexarotene, aka Targretin, made headlines when researchers reported that it quickly lowered Aβ in the brain, reduced amyloid plaques, and improved learning and memory in mice that mimic salient features of Alzheimer's disease (AD).
For neuroscientists studying the intricate mechanisms of hearing in the brain's auditory cortex, a major question has been how a listener can focus in a noisy environment, and how neurochemicals help neurons convey as much embedded information as possible for the rest of the brain to act on.
› Verified 4 days ago
Dr. Ruchit D Shah, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-7146 | |
Hashim Sadig, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2514 S 102nd St, 160, West Allis, WI 53227 Phone: 414-225-0300 | |
Dr. Monica M O'sullivan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11211 W Lincoln Ave, West Allis, WI 53227 Phone: 414-454-8300 Fax: 414-327-1450 | |
Neil Reisinger, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 904 S 114th St, West Allis, WI 53214 Phone: 414-259-9234 | |
Dr. Isaac Olabode Taiwo, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 8901 W Lincoln Ave, West Allis, WI 53227 Phone: 414-328-6000 Fax: 414-649-1328 | |
Dr. Susan L Darmstadter, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8905 W Lincoln Ave, Ste 401, West Allis, WI 53227 Phone: 414-328-8270 |